Beam Therapeutics Inc.
risto-cel
sickle cell disease
Date
TBD
Approval decision · Date TBD estimated
What's at stake
A final FDA approval decision on risto-cel for sickle cell disease is expected Date TBD.
Primary source
· SEC 8-K
verified 13h ago
“Beam expects to submit a BLA for risto-cel as early as year-end 2026.”